(Q36395509)

13 August 2017

1 reference

title

Diagnosis and prognosis of early rheumatoid arthritis, with special emphasis on laboratory analysis (English)

1 reference

13 August 2017

1 reference

Rudolf Mierau

1

1 reference

13 August 2017

Ekkehard Genth

series ordinal

2

1 reference

13 August 2017

publication date

1 January 2006

1 reference

Clinical Chemistry and Laboratory Medicine

13 August 2017

published in

1 reference

13 August 2017

volume

44

1 reference

13 August 2017

issue

2

1 reference

13 August 2017

page(s)

138-143

1 reference

Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

Clinical utility of the anti-CCP assay in patients with rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

Prognostic factors in early rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

Presence of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

Diagnostic value of anti-cyclic citrullinated peptide antibodies to detect rheumatoid arthritis in patients with Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

Anti-cyclic citrullinated peptide antibodies in patients with primary Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

Prevalence and clinical significance of anti-cyclic citrullinated peptide and antikeratin antibodies in palindromic rheumatism. An abortive form of rheumatoid arthritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

Antibodies against cyclic citrullinated peptide (CCP) and levels of cartilage oligomeric matrix protein (COMP) in very early arthritis: relation to diagnosis and disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

Clinical utility of anti-CCP antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

When does rheumatoid arthritis begin and why do we need to know?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

Second generation anti-cyclic citrullinated peptide (anti-CCP2) antibodies can replace other anti-filaggrin antibodies and improve rheumatoid arthritis diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

Anti-cyclic citrullinated peptide autoantibodies measured by an automated enzyme immunoassay: analytical performance and clinical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

Autoantibodies recognizing citrullinated rat filaggrin in an ELISA using citrullinated and non-citrullinated recombinant proteins as antigens are highly diagnostic for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

Absence of antibodies to cyclic citrullinated peptide in sera of patients with hepatitis C virus infection and cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

Diagnostic accuracy of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

Impact of shared epitope genotype and ethnicity on erosive disease: a meta-analysis of 3,240 rheumatoid arthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

Time to first occurrence of erosions in inflammatory polyarthritis: results from a prospective community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

How to diagnose rheumatoid arthritis early: A prediction model for persistent (erosive) arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.026

21 January 2018

Identifiers

DOI

10.1515/CCLM.2006.026

1 reference

13 August 2017

1 reference